Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Respiratory Aspiration 3Neoplasms 3Neurofibromatosis 1 2Lung Neoplasms 2Postoperative Complications 1Postoperative Cognitive Complications 1Lymphoma, Follicular 1Delirium 1Carcinoma, Non-Small-Cell Lung 1Attention Deficit Disorder with Hyperactivity 1Acute Lung Injury 1

Interventions

Sertraline 1Selective Serotonin Reuptake Inhibitors 1N-monoacetylcystine 1Magnetoencephalography 1Inhalation 1Cytidine Triphosphate 1Control Groups 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Attention Deficit Disorder with Hyperactivity × Inhalation × Clear all
NCT04481048 2026-06-05

DoDNAC

Children's Hospital Medical Center, Cincinnati

Phase 2 Completed
25 enrolled 12 charts
CNS

Attention Deficit Disorder with Hyperactivity, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡